<DOC>
	<DOCNO>NCT00382174</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability effectiveness Thymosin Beta 4 administer topically patient Pressure Ulcers</brief_summary>
	<brief_title>Study Thymosin Beta 4 Patients With Pressure Ulcers</brief_title>
	<detailed_description>The purpose double-blind , placebo-controlled , dose-escalation study evaluate safety , tolerability effectiveness Thymosin Beta 4 ( Tβ4 ) , administer topically , patient Pressure Ulcers ( PU ) . PU cause prolonged pressure rub body area prone moisture friction . PU affect primarily elderly , bedridden patient . Tβ4 synthetically-produced copy naturally-occurring 43 amino acid peptide wound heal anti-inflammatory property up-regulate expression laminin-5 .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Pressure Ulcer</mesh_term>
	<criteria>Inclusion criterion : Informed Consent Form sign patient patient 's legal representative Inpatients outpatient At least 1 PU fullthickness skin loss joint capsule bone exposure Surface area 5 70 cm2 Ulcer present stable least 1 month enrollment Use experimental drug , participation clinical study , within 60 day enrollment Use immunotherapy , cytotoxic chemotherapy within 60 day enrollment . Systemic steroid allow 30 day prior enrollment . Topical therapy steroidal allow 7 day prior enrollment History adverse event ingredient study medication Neurological , cardiovascular , respiratory , hepatic , renal , metabolic disease likely interfere patient 's participation completion study Arterial venous disorder result ulcerated wound Diabetes mellitus except disease determine control glycosylated hemoglobin ≤8.5 % total hemoglobin Pregnancy breastfeeding study . ( A serum pregnancy test perform Screening female patient childbearing potential . )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>pressure ulcer</keyword>
	<keyword>cutaneous wound- healing</keyword>
	<keyword>chronic wound-healing</keyword>
	<keyword>Thymosin Beta 4</keyword>
	<keyword>laminin-5</keyword>
</DOC>